{"id":"W2891078672","doi":"10.1038/s41416-018-0164-0","title":"Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Exelixis; Memorial Sloan-Kettering Cancer Center","keywords":"Cabozantinib; Pazopanib; Sunitinib; Medicine; Everolimus; Renal cell carcinoma; Internal medicine; Oncology; Urology; Progression-free survival; Tyrosine-kinase inhibitor; Surgery; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003487054,0.0007080191,0.001764881,0.0002790568,0.0003818998,0.0008707166,0.0004490337,0.0007734225,0.002124417],"category_scores_gemma":[0.002873483,0.0002038635,0.002685181,0.0003750656,0.0003829397,0.0006555101,0.0005121063,0.001776779,0.0001722252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007146451,"about_ca_system_score_gemma":0.0008493201,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007415006,"about_ca_topic_score_gemma":0.002513383,"domain_scores_codex":[0.9984025,0.0008922431,0.0001250909,0.0002185393,0.0002038392,0.0001577013],"domain_scores_gemma":[0.9974561,0.0007699335,0.0009425327,0.0001674191,0.0001194315,0.0005445166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.852678,0.001881183,0.09882253,0.0007642156,0.008897402,0.0001380277,0.0001053004,0.002674808,0.00287214,0.0002181086,0.002376465,0.02857185],"study_design_scores_gemma":[0.2420006,0.1118501,0.6121951,0.0003692821,0.01391237,0.0009261573,0.000202493,0.006459972,0.003576617,0.001746979,0.006626989,0.000133256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914579,0.005514096,0.0001694318,0.0002294894,0.00008710968,0.0002036534,0.0009366549,0.00001430434,0.001387457],"genre_scores_gemma":[0.9964435,0.0007289554,0.0001659011,0.0002146625,0.0001378718,0.0002348218,0.001823641,0.000005653618,0.0002450884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003487054,"threshold_uncertainty_score":0.0184415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03876065357668174,"score_gpt":0.3488410741432547,"score_spread":0.3100804205665729,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}